Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 650

1.

Association of Post-Traumatic Stress Disorder Symptoms Following Hurricane Katrina With Incident Cardiovascular Disease Events Among Older Adults With Hypertension.

Lenane Z, Peacock E, Joyce C, Frohlich ED, Re RN, Muntner P, Krousel-Wood M.

Am J Geriatr Psychiatry. 2019 Mar;27(3):310-321. doi: 10.1016/j.jagp.2018.11.006. Epub 2018 Nov 25.

PMID:
30581139
2.

Effects of Tobacco on Health and Disease: Three Decades of the Alton Ochsner Award.

Frohlich ED.

Ochsner J. 2017 Fall;17(3):265-269. No abstract available.

3.

Evolution of American Academic Medicine: A View of Its Contributions to World Medicine and Reflections Influenced by Personal Role Models.

Frohlich ED.

Curr Probl Cardiol. 2017 Aug;42(8):236-253. doi: 10.1016/j.cpcardiol.2017.05.002. Epub 2017 May 20.

PMID:
28709475
4.

Walmor C. De Mello: "Your Heart Is Still With Us".

Ferrario CM, Frohlich ED, Gerena Y.

Hypertension. 2017 Jun;69(6):992-993. doi: 10.1161/HYPERTENSIONAHA.117.09307. Epub 2017 Apr 10. No abstract available.

PMID:
28396538
5.

Continuing Challenges and Unresolved Problems in Hypertensive Diseases.

Frohlich ED.

Med Clin North Am. 2017 Jan;101(1):xix-xxi. doi: 10.1016/j.mcna.2016.10.002. No abstract available.

PMID:
27884239
6.

Hypertension: New and Future Challenges.

Frohlich ED.

Med Clin North Am. 2017 Jan;101(1):1-6. doi: 10.1016/j.mcna.2016.08.018.

PMID:
27884221
7.

Hyperuricemia: A Biomarker of Renal Hemodynamic Impairment.

Susic D, Frohlich ED.

Cardiorenal Med. 2015 Jun;5(3):175-82. doi: 10.1159/000381317. Review.

8.

Coronary heart disease risk factors: public impact of initial and later-announced risks.

Frohlich ED, Quinlan PJ.

Ochsner J. 2014 Winter;14(4):532-7. No abstract available.

9.

Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO).

Krousel-Wood M, Holt E, Joyce C, Ruiz R, Dornelles A, Webber LS, Morisky DE, Frohlich ED, Re RN, He J, Whelton PK, Muntner P.

J Hypertens. 2015 Feb;33(2):412-20. doi: 10.1097/HJH.0000000000000382.

10.

Telmisartan improves survival and ventricular function in SHR rats with extensive cardiovascular damage induced by dietary salt excess.

Susic D, Frohlich ED.

J Am Soc Hypertens. 2014 May;8(5):297-302. doi: 10.1016/j.jash.2014.02.009. Epub 2014 Feb 25.

PMID:
24726099
11.

Clinical perspectives and fundamental aspects of local cardiovascular and renal Renin-Angiotensin systems.

De Mello WC, Frohlich ED.

Front Endocrinol (Lausanne). 2014 Feb 19;5:16. doi: 10.3389/fendo.2014.00016. eCollection 2014. Review.

12.

Editorial - reflections on a professional career blessed with teachers, mentors, and role models.

Frohlich ED.

Ochsner J. 2013 Winter;13(4):486-8. No abstract available.

13.

Left ventricular hypertrophy: a major factor of risk in Black hypertensive patients.

Frohlich ED.

Am J Hypertens. 2014 Jan;27(1):1-2. doi: 10.1093/ajh/hpt214. Epub 2013 Nov 16. No abstract available.

PMID:
24242824
14.

Salt in health and disease--a delicate balance.

Kotchen TA, Cowley AW Jr, Frohlich ED.

N Engl J Med. 2013 Jun 27;368(26):2531-2. doi: 10.1056/NEJMc1305326. No abstract available.

PMID:
23802533
15.

Salt in health and disease--a delicate balance.

Kotchen TA, Cowley AW Jr, Frohlich ED.

N Engl J Med. 2013 Mar 28;368(13):1229-37. doi: 10.1056/NEJMra1212606. Review. No abstract available.

PMID:
23534562
16.

Leadership in american medicine as I see it: a background in the beginning.

Frohlich ED.

Ochsner J. 2012 Winter;12(4):302-7. No abstract available.

17.

Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations.

Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LV.

Circulation. 2012 Dec 11;126(24):2880-9. doi: 10.1161/CIR.0b013e318279acbf. Epub 2012 Nov 2. Erratum in: Circulation. 2013 Jan 1;27(1):e263.

PMID:
23124030
18.

Nebivolol prevents myocardial fibrosis and diastolic dysfunction in salt-loaded spontaneously hypertensive rats.

Susic D, Fares H, Frohlich ED.

J Am Soc Hypertens. 2012 Sep-Oct;6(5):316-23. doi: 10.1016/j.jash.2012.06.001.

PMID:
22995800
19.

Telmisartan prevents excess-salt-induced exacerbated (malignant) hypertension in spontaneously hypertensive rats.

Susic D, Fares H, Frohlich ED.

J Cardiovasc Pharmacol Ther. 2013 Mar;18(2):126-32. doi: 10.1177/1074248412458155. Epub 2012 Aug 27.

PMID:
22927675
20.

Renal denervation using an irrigated radiofrequency ablation catheter for management of drug-resistant hypertension: a demonstrated value?

Frohlich ED.

JACC Cardiovasc Interv. 2012 Jul;5(7):766-8. doi: 10.1016/j.jcin.2012.02.019. No abstract available.

21.

Hypertensive Cardiovascular and Renal Disease and Target Organ Damage: Lessons from Animal Models.

Susic D, Frohlich ED.

Cardiorenal Med. 2011;1(3):139-146. doi: 10.1159/000329334. Epub 2011 Jun 25.

22.

Salt consumption and cardiovascular, renal, and hypertensive diseases: clinical and mechanistic aspects.

Susic D, Frohlich ED.

Curr Opin Lipidol. 2012 Feb;23(1):11-6. doi: 10.1097/MOL.0b013e32834d9c52. Review.

PMID:
22123673
23.

Pressure overload.

Frohlich ED, Susic D.

Heart Fail Clin. 2012 Jan;8(1):21-32. doi: 10.1016/j.hfc.2011.08.005. Review.

PMID:
22108724
24.

Sodium and its multiorgan targets.

Frohlich ED, Susic D.

Circulation. 2011 Oct 25;124(17):1882-5. doi: 10.1161/CIRCULATIONAHA.111.029371. Review. No abstract available.

PMID:
22025637
25.

Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults.

Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber LS, Morisky DE, Frohlich ED, Re RN.

Hypertension. 2011 Nov;58(5):804-10. doi: 10.1161/HYPERTENSIONAHA.111.176859. Epub 2011 Oct 3.

26.
27.

Quality of life in hypertensive clinic patients following hurricane katrina.

Stanley E, Muntner P, Re RN, Frohlich ED, Holt E, Krousel-Wood MA.

Ochsner J. 2011 Fall;11(3):226-31.

28.

Novel concepts in the genesis of hypertension: role of LOX-1.

Luo P, Yan M, Frohlich ED, Mehta JL, Hu C.

Cardiovasc Drugs Ther. 2011 Oct;25(5):441-9. doi: 10.1007/s10557-011-6337-1. Review.

PMID:
21912849
29.

Epidemiological issues are not simply black and white.

Frohlich ED.

Hypertension. 2011 Oct;58(4):546-7. doi: 10.1161/HYPERTENSIONAHA.111.178541. Epub 2011 Sep 12. No abstract available.

PMID:
21911712
30.

Generic drugs: the good, the bad, and the unknown.

Frohlich ED.

Ochsner J. 2011 Summer;11(2):98. No abstract available.

31.

On the local cardiac renin angiotensin system. Basic and clinical implications.

De Mello WC, Frohlich ED.

Peptides. 2011 Aug;32(8):1774-9. doi: 10.1016/j.peptides.2011.06.018. Epub 2011 Jun 25. Review.

PMID:
21729730
32.

Salt-induced renal injury in SHRs is mediated by AT1 receptor activation.

Susic D, Frohlich ED, Kobori H, Shao W, Seth D, Navar LG.

J Hypertens. 2011 Apr;29(4):716-23. doi: 10.1097/HJH.0b013e3283440683.

33.

The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association.

Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC Jr, Vafiadis DK, Van Horn LV.

Circulation. 2011 Mar 15;123(10):1138-43. doi: 10.1161/CIR.0b013e31820d0793. Epub 2011 Jan 13. No abstract available.

PMID:
21233236
34.

Sodium exacerbates ambulatory heart failure or hypertensive disease.

Frohlich ED.

Am J Clin Nutr. 2011 Feb;93(2):229-31. doi: 10.3945/ajcn.110.008565. Epub 2011 Jan 5. No abstract available.

PMID:
21209223
35.

Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy.

Frohlich ED, González A, Díez J.

J Hypertens. 2011 Jan;29(1):17-26. doi: 10.1097/HJH.0b013e328340d787. Review.

PMID:
21045723
36.

Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO.

Krousel-Wood M, Islam T, Muntner P, Holt E, Joyce C, Morisky DE, Webber LS, Frohlich ED.

Ann Behav Med. 2010 Dec;40(3):248-57. doi: 10.1007/s12160-010-9217-1.

37.

Hypertension and depression: coexisting barriers to medication adherence.

Krousel-Wood MA, Frohlich ED.

J Clin Hypertens (Greenwich). 2010 Jul 1;12(7):481-6. doi: 10.1111/j.1751-7176.2010.00302.x. No abstract available.

38.

Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group.

Eagle KA, Ginsburg GS, Musunuru K, Aird WC, Balaban RS, Bennett SK, Blumenthal RS, Coughlin SR, Davidson KW, Frohlich ED, Greenland P, Jarvik GP, Libby P, Pepine CJ, Ruskin JN, Stillman AE, Van Eyk JE, Tolunay HE, McDonald CL, Smith SC Jr.

Circulation. 2010 Mar 30;121(12):1447-54. doi: 10.1161/CIRCULATIONAHA.109.904029. Review. No abstract available.

39.

Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess.

Susic D, Varagic J, Frohlich ED.

Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1177-81. doi: 10.1152/ajpheart.00866.2009. Epub 2010 Jan 29.

40.

A translational approach to hypertensive heart disease.

Díez J, Frohlich ED.

Hypertension. 2010 Jan;55(1):1-8. doi: 10.1161/HYPERTENSIONAHA.109.141887. Epub 2009 Nov 23. Review. No abstract available.

PMID:
19933923
41.

Role of beta-adrenergic receptor blocking agents in hypertensive diseases: personal thoughts as the controversy persists.

Frohlich ED.

Ther Adv Cardiovasc Dis. 2009 Dec;3(6):455-64. doi: 10.1177/1753944709346519. Epub 2009 Nov 6. Review.

PMID:
19897523
42.

Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension.

Lacolley P, Safar ME, Regnault V, Frohlich ED.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1567-75. doi: 10.1152/ajpheart.00622.2009. Epub 2009 Sep 4. Review.

43.

Current challenges and unresolved problems in hypertensive disease.

Frohlich ED.

Med Clin North Am. 2009 May;93(3):527-40, Table of Contents. doi: 10.1016/j.mcna.2009.02.004. Review.

PMID:
19427489
44.

Hypertensive disease: current challenges, new concepts and management. Preface.

Frohlich ED.

Med Clin North Am. 2009 May;93(3):xv-xx. doi: 10.1016/j.mcna.2009.02.016. No abstract available.

PMID:
19427488
45.

Usefulness of heart rate as an independent predictor for survival after heart transplantation.

Anand RG, Reddy MT, Yau CL, Myers L, Amin RR, Stahls PF, Dumas D, Frohlich ED, Ventura HO.

Am J Cardiol. 2009 May 1;103(9):1290-4. doi: 10.1016/j.amjcard.2009.01.022. Epub 2009 Mar 13.

PMID:
19406274
46.

Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats.

Susic D, Zhou X, Frohlich ED.

Am J Nephrol. 2009;29(6):639-45. doi: 10.1159/000195633. Epub 2009 Jan 21.

PMID:
19155618
47.

Salt, arterial pressure, and cardiovascular and renal damage.

Susic D, Fares H, Frohlich ED.

Ochsner J. 2009 Winter;9(4):197-203.

48.
49.

Obesity: a central risk and cardiovascular target of the cardiometabolic syndrome.

Frohlich ED.

J Cardiometab Syndr. 2008 Summer;3(3):147-8. doi: 10.1111/j.1559-4572.2008.00007.x. No abstract available.

50.

Medication adherence in older clinic patients with hypertension after Hurricane Katrina: implications for clinical practice and disaster management.

Krousel-Wood MA, Islam T, Muntner P, Stanley E, Phillips A, Webber LS, Frohlich ED, Re RN.

Am J Med Sci. 2008 Aug;336(2):99-104. doi: 10.1097/MAJ.0b013e318180f14f.

Supplemental Content

Loading ...
Support Center